Avalo Therapeutics (AVTX) Tax Rate (2017 - 2026)

Avalo Therapeutics (AVTX) has 10 years of Tax Rate data on file, last reported at 0.06% in Q1 2026.

• For the quarter ending Q1 2026, Tax Rate changed 0.0% year-over-year to 0.06%; the trailing twelve-month figure through Mar 2026 stood at 0.2% (down 36.0% YoY), and the FY2025 full-year result was 0.21%, up 11.0% from the prior year.
• Tax Rate for Q1 2026 stood at 0.06%, up from 0.96% in the prior quarter.
• Across five years, Tax Rate topped out at 0.16% in Q3 2022 and bottomed at 0.96% in Q4 2025.
• The 5-year median for Tax Rate is 0.06% (2025), against an average of 0.11%.
• Peak annual rise in Tax Rate reached 20 bps in 2022, while the deepest fall reached 118 bps in 2022.
• A 5-year view of Tax Rate shows it stood at 0.08% in 2022, then soared by 235 bps to 0.11% in 2023, then tumbled by 394 bps to 0.32% in 2024, then slumped by 196 bps to 0.96% in 2025, then soared by 94 bps to 0.06% in 2026.
• The last three Tax Rate figures came in at 0.06% (Q1 2026), 0.96% (Q4 2025), and 0.04% (Q3 2025), per Business Quant data.

Peer Comparison